HK1182315A1 - 穩定的隨時可用的對乙酰氨基酚注射製劑 - Google Patents

穩定的隨時可用的對乙酰氨基酚注射製劑

Info

Publication number
HK1182315A1
HK1182315A1 HK13109609.9A HK13109609A HK1182315A1 HK 1182315 A1 HK1182315 A1 HK 1182315A1 HK 13109609 A HK13109609 A HK 13109609A HK 1182315 A1 HK1182315 A1 HK 1182315A1
Authority
HK
Hong Kong
Prior art keywords
use injectable
stable ready
paracetamol formulation
injectable paracetamol
formulation
Prior art date
Application number
HK13109609.9A
Other languages
English (en)
Inventor
伊歐利亞．特塞提
Original Assignee
聯康藥業克雷恩特塞提斯製藥實驗室有限責任公司
伊歐利亞．特塞提
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 聯康藥業克雷恩特塞提斯製藥實驗室有限責任公司, 伊歐利亞．特塞提 filed Critical 聯康藥業克雷恩特塞提斯製藥實驗室有限責任公司
Publication of HK1182315A1 publication Critical patent/HK1182315A1/zh

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A61K31/167—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the nitrogen of a carboxamide group directly attached to the aromatic ring, e.g. lidocaine, paracetamol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/20—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing sulfur, e.g. dimethyl sulfoxide [DMSO], docusate, sodium lauryl sulfate or aminosulfonic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/22—Heterocyclic compounds, e.g. ascorbic acid, tocopherol or pyrrolidones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/40—Cyclodextrins; Derivatives thereof

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Inorganic Chemistry (AREA)
  • Pain & Pain Management (AREA)
  • Dermatology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
HK13109609.9A 2010-05-19 2013-08-16 穩定的隨時可用的對乙酰氨基酚注射製劑 HK1182315A1 (zh)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP10005258A EP2389923B1 (en) 2010-05-19 2010-05-19 Stable ready to use injectable paracetamol formulation
PCT/EP2011/002482 WO2011144335A1 (en) 2010-05-19 2011-05-18 Stable ready to use injectable paracetamol formulation

Publications (1)

Publication Number Publication Date
HK1182315A1 true HK1182315A1 (zh) 2013-11-29

Family

ID=42338244

Family Applications (1)

Application Number Title Priority Date Filing Date
HK13109609.9A HK1182315A1 (zh) 2010-05-19 2013-08-16 穩定的隨時可用的對乙酰氨基酚注射製劑

Country Status (22)

Country Link
US (1) US8877817B2 (zh)
EP (1) EP2389923B1 (zh)
CN (1) CN102985069B (zh)
AP (1) AP3151A (zh)
BR (1) BR112012029212A2 (zh)
CA (1) CA2799666C (zh)
CY (1) CY1113999T1 (zh)
DK (1) DK2389923T3 (zh)
ES (1) ES2403121T3 (zh)
HK (1) HK1182315A1 (zh)
HR (1) HRP20130184T1 (zh)
MA (1) MA34314B1 (zh)
MY (1) MY160458A (zh)
PL (1) PL2389923T3 (zh)
PT (1) PT2389923E (zh)
RU (1) RU2519764C1 (zh)
SI (1) SI2389923T1 (zh)
SM (1) SMT201300038B (zh)
TN (1) TN2012000516A1 (zh)
UA (1) UA104381C2 (zh)
WO (1) WO2011144335A1 (zh)
ZA (1) ZA201208605B (zh)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZA201300398B (en) * 2012-11-27 2013-09-25 Genfarma Laboratories S L Injectable liquid formulation of the combination of tramadol and paracetamol
WO2016008546A1 (en) * 2014-07-18 2016-01-21 Everbright Pharmaceuticals S.A.R.L. Aqueous formulation comprising paracetamol and ibuprofen
CN105797166A (zh) * 2016-03-30 2016-07-27 吉林长白山药业集团股份有限公司 用羟丙基环糊精包合对乙酰氨基酚制成液体制剂的方法
WO2018192664A1 (en) 2017-04-20 2018-10-25 Hyloris Developments Sa METHOD FOR PREPARING A COMPOSITION WITH A LOW DISSOLVED OXYGEN CONTENT, COMPRISING ACETAMINOPHEN, AND OPTIONALLY ONE OR MORE NSAIDs, AND A COMPOSITION OBTAINED THEREOF
WO2019180072A1 (en) 2018-03-22 2019-09-26 Bayer Pharma Aktiengesellschaft Parenteral pharmaceutical composition comprising neladenoson bialanate
US20230165928A1 (en) * 2020-04-30 2023-06-01 Blue Sky Innovation, Llc Compositions and methods comprising stable reduced glutathione
GR1010637B (el) * 2023-01-13 2024-02-15 Ιουλια Κλεωνος Τσετη Σταθερο υδατικο διαλυμα παρακεταμολης για χρηση σε ενδοφλεβια εγχυση

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH648371A5 (de) 1982-01-29 1985-03-15 Fischer Ag Georg Anschlusseinrichtung fuer armaturen.
US4727064A (en) 1984-04-25 1988-02-23 The United States Of America As Represented By The Department Of Health And Human Services Pharmaceutical preparations containing cyclodextrin derivatives
FR2751875B1 (fr) 1996-08-05 1998-12-24 Scr Newpharm Nouvelles formulations liquides stables a base de paracetamol et leur mode de preparation
JP2001233787A (ja) * 2000-02-04 2001-08-28 Patents Exploitation Co Bv 小・中サイズのペプチド含有薬学的組成物
US20040045546A1 (en) * 2002-09-05 2004-03-11 Peirce Management, Llc Pharmaceutical delivery system for oral inhalation through nebulization consisting of inert substrate impregnated with substance (S) to be solubilized or suspended prior to use
FR2851164B1 (fr) * 2003-02-14 2005-04-22 Xuan Tho Nguyen Formulation liquide injectable de paracetamol
US9399012B2 (en) * 2007-11-13 2016-07-26 Mallinckrodt Ip Reduced dose intravenous acetaminophen
WO2009098716A2 (en) * 2008-01-17 2009-08-13 Aptuit Laurus Private Limited Stable pharmaceutical aqueous compositions
US20090246276A1 (en) * 2008-01-28 2009-10-01 Graham Jackson Pharmaceutical Compositions
EP2253323B1 (en) * 2008-02-29 2019-04-10 Meiji Co., Ltd. Anti-allergic agent

Also Published As

Publication number Publication date
CY1113999T1 (el) 2016-07-27
EP2389923A1 (en) 2011-11-30
WO2011144335A8 (en) 2012-12-06
DK2389923T3 (da) 2013-03-18
CN102985069A (zh) 2013-03-20
CA2799666C (en) 2016-02-16
ZA201208605B (en) 2013-09-25
ES2403121T3 (es) 2013-05-14
US20130210922A1 (en) 2013-08-15
WO2011144335A1 (en) 2011-11-24
CA2799666A1 (en) 2011-11-24
MA34314B1 (fr) 2013-06-01
AP2012006597A0 (en) 2012-12-31
PL2389923T3 (pl) 2013-06-28
MY160458A (en) 2017-03-15
EP2389923B1 (en) 2013-01-30
UA104381C2 (uk) 2014-01-27
PT2389923E (pt) 2013-03-28
SI2389923T1 (sl) 2013-06-28
CN102985069B (zh) 2014-11-26
SMT201300038B (it) 2013-07-09
AP3151A (en) 2015-03-31
RU2519764C1 (ru) 2014-06-20
HRP20130184T1 (hr) 2013-05-31
TN2012000516A1 (en) 2014-04-01
US8877817B2 (en) 2014-11-04
BR112012029212A2 (pt) 2020-09-29

Similar Documents

Publication Publication Date Title
DK2387989T3 (da) Langtidsvirkende formuleringer med insuliner
PL2616064T3 (pl) Gotowe do zastosowania formulacje ketorolaku
GB201010193D0 (en) Medicinal use
EP2685965A4 (en) COMBINED FORMULATION WITH INCREASED STABILITY
DK2525798T3 (da) Anæstetisk formulering
ZA201208726B (en) High-temperature stable oxygen-carrier-containing pharmaceutical composition
IL221857A (en) Liquid formulations are stabilized
HK1182315A1 (zh) 穩定的隨時可用的對乙酰氨基酚注射製劑
EP2599484A4 (en) INJECTABLE PHARMACEUTICAL PREPARATION OF MELPHALANE
HK1205877A1 (zh) 可注射布洛芬製劑
GB201121476D0 (en) Novel pharmaceutical formulation
ZA201206589B (en) Incotine containing formulation
PL2521445T3 (pl) Preparat i jego zastosowanie
GB201003218D0 (en) Improvements relating to platform devices
HK1153400A1 (zh) 穩定的即用可注射撲熱息痛製劑
IL206739A0 (en) Injectable pharmaceutical composition
EP2536693A4 (en) SUBSTITUTED 2-IMIDAZOLIDONES AND THE LIKE
GB201311029D0 (en) Pre-filled sing-use syringe
EP2536688A4 (en) STABLE DOSAGE FORMS OF LEVOMILNACIPRAN
GB201005992D0 (en) Formulation
GB201001978D0 (en) Formulation
PL393180A1 (pl) Preparat weterynaryjny
PL390421A1 (pl) Preparat weterynaryjny

Legal Events

Date Code Title Description
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)

Effective date: 20200517